Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Mol Cancer Ther. 2009 Jul 28;8(8):2122–2130. doi: 10.1158/1535-7163.MCT-09-0115

Figure 4.

Figure 4

Dose and time dependent of PPP down-regulated IGF-1R proteins in drug resistant osteosarcoma cells. U-2OSMR was treated with PPP in dose (A) or time (B) dependent manner in fresh complete medium. Total cellular proteins were subjected to immunoblotting with specific antibodies to IGF-1R, pIGF-1R, AKT and β-actin as described in “Materials and Methods”. A: PPP reduces IGF-1R proteins in U-2OSMR cells as dose dependent manner. U-2OSMR cells were cultured for 24 h in the presence of various concentrations of PPP as indicated. B: U-2OSMR cells were cultured for the time indicated (in hours) in the presence of 1 μM of PPP. C and D: Western blots from A and B were analyzed using densitometry as described in “Materials and Methods”.

HHS Vulnerability Disclosure